Association of a Functional Polymorphism in the Serotonin Transporter Gene With Abnormal Emotional Processing in Ecstasy Users
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The long-term effects of the use of 3,4-methylenedioxymethamphetamine (MDMA, or Ecstasy) in humans are controversial and unclear. The authors' goal was to assess the contribution of a functional polymorphism in the gene encoding serotonin transporter to changes in emotional processing following chronic Ecstasy use. METHOD: They investigated Beck Depression Inventory scores and performance on the Affective Go/No-Go test, a computerized neuropsychological test sensitive to emotional processing, in Ecstasy users and comparison subjects, stratifying the results by serotonin transporter genotype. RESULTS: Ecstasy use was associated with higher Beck Depression Inventory score and abnormalities in the Affective Go/No-Go test in individuals with the ss and ls genotype but not those with the ll genotype. CONCLUSIONS: Ecstasy users carrying the s allele, but not comparison subjects carrying the s allele, showed abnormal emotional processing. On the basis of a comparison with acute tryptophan depletion, the authors hypothesize that chronic Ecstasy use may cause long-term changes to the serotonin system, and that Ecstasy users carrying the s allele may be at particular risk for emotional dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Emotional bias and inhibitory control processes in mania and depression
MURPHY, F. C., SAHAKIAN, B. J., RUBINSZTEIN, J. S., MICHAEL, A., ROGERS, R. D., ROBBINS, T. W., & PAYKEL, E. S. (1999) · Psychological Medicine · doi:10.1017/s0033291799001233 · Cited by 659
Self-citationThe effects of tryptophan depletion on cognitive and affective processing in healthy volunteers
Murphy, F., Smith, K., Cowen, P., Robbins, T., & Sahakian, B. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1128-9 · Cited by 255
Self-citationNeumeister, A., Konstantinidis, A., Stastny, J., Schwarz, M. J., Vitouch, O., Willeit, M., Praschak-Rieder, N., Zach, J., de Zwaan, M., Bondy, B., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.613 · Cited by 223 · cited 1×
“mood change under acute tryptophan depletion, while ll individuals show little or no mood change (20), a result concordant with our finding that ss Ecstasy users were the”
ResultThe effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression
McLean, A., Rubinsztein, J. S., Robbins, T. W., & Sahakian, B. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1586-8 · Cited by 125
Cited by
Verdejo-García, A., Lawrence, A. J., & Clark, L. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.11.003 · Cited by 1,422
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535
Self-citationToxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
The genetics of bipolar disorder
Barnett, J. H., & Smoller, J. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.080 · Cited by 407
Serotonergic vulnerability and depression: assumptions, experimental evidence and implications
Jans, L. A. W., Riedel, W. J., Markus, C. R., & Blokland, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001920 · Cited by 374
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
Capela, J. P., Carmo, H., Remião, F., Bastos, M. L., Meisel, A., & Carvalho, F. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8064-1 · Cited by 290
Roiser, J. P., Müller, U., Clark, L., & Sahakian, B. J. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570600705x · Cited by 117
“Seven of the participants (3 ll, 4 ss) completing the ATD protocol were included as controls in a previous study (Roiser et al., 2005).”
BackgroundMethodSelf-citationRoiser, J. P., Blackwell, A. D., Cools, R., Clark, L., Rubinsztein, D. C., Robbins, T. W., & Sahakian, B. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301055 · Cited by 98
“The s allele has been associated with increased sensitivity to ATD in women (Neumeister et al , 2002), and recently Roiser et al (2005) reported that possession of the s allele was associated with increased vulnerability to emotional disturbance following chronic ecstasy use, which is thought to…”
Self-citationCOMT val158met and 5-HTTLPR Genetic Polymorphisms Moderate Executive Control in Cannabis Users
Verdejo-García, A., Fagundo, A. B., Cuenca, A., Rodriguez, J., Cuyás, E., Langohr, K., de Sola Llopis, S., Civit, E., Farré, M., Peña-Casanova, J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.59 · Cited by 53
Marsh, A. A., Finger, E. C., Buzas, B., Soliman, N., Richell, R. A., Vythilingham, M., Pine, D. S., Goldman, D., & Blair, R. J. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0581-2 · Cited by 52
“Individuals carrying the short (s) allele of this gene show increased sensitivity to serotonergic manipulation relative to long (l) allele homozygotes (Neumeister et al. 2002; Roiser et al. 2005, 2006).”
Background
Metadata
- Authors
- Roiser, J. P., Cook, L. J., Cooper, J. D., Rubinsztein, D. C., & Sahakian, B. J.
- Venue
- American Journal of Psychiatry
- Published
- 2005-03-01
- Volume
- 162
- Issue
- 3
- Pages
- 609-612
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2160576289
- Cited by
- 81
- References
- 5
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.